Navigation Links
Panacea To Market Measles Vaccine In India

Homegrown pharma major Panacea Biotec today said it is working on four vaccines, including those for treating anthrax and Japanese encephalitis. //

"We are currently working on four vaccines for anthrax, dengue, Japanese encephalitis and hepatitis-A. Phase I and II trials for anthrax vaccine have been completed, which is ready for regulatory approvals," Panacea Biotec Joint Managing Director Rajesh Jain told reporters here today.

The company would also set up its fifth R&D centre, with a strength of 100 scientists, in Navi Mumbai, he said adding, the centre would be operational by next year.

Panacea today entered into a manufacturing and marketing agreement with Indonesian state-run drug company, PT Bio Farma, to supply their measles vaccine in India as well as other global markets.

As part of the agreement, the company would procure bulk vaccines from PT Bio Farma and formulate it into a finished product, which would be sold in India and other defined global markets.

"There is a shortage of measles vaccine in the Indian market with only one company manufacturing such formulations. Panacea plans to fill this demand supply gap with this new deal," Jain said.

The medicine is expected to be ready by end of 2007 and would be available in the market by 2008, he said.

Apart from India, the company would also market the vaccine to UNICEF, African countries, Latin America, Asian region and countries in the middle east, Jain added.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Panacea Biotech To Market Anthrax Vaccine
2. Panacea Biotec In-Licenses FMD Vaccine
3. Websites That Offer Panacea for Eating Disorders may Be Dangerous
4. Panacea Biotech To Market Anthrax Vaccine
5. Ranbaxy Labs Entry Into Anti-Acne Market
6. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
7. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
8. Donated Mothers Milk To Hit The Market
9. New Four- in- one Vaccine For DTP & Hepatitis To Hit The Indian Market
10. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
11. Junk Food Marketing to be banned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: